FDA QMSR
37 articles
Medical Device Cybersecurity Patch Management: Regulated Update Deployment Under EU MDR, FDA Section 524B, and the Cyber Resilience Act (2026)
How to deploy cybersecurity patches to fielded medical devices while maintaining MDR conformity, FDA Section 524B postmarket obligations, and Cyber Resilience Act vulnerability handling timelines — covering risk-based triage, change control classification, coordinated disclosure integration with PSIRT, and the operational QMS workflow from vulnerability detection to verified field deployment.
FDA Servicing vs Remanufacturing Decision Tree for Medical Devices: How to Classify Your Activities Under the May 2024 Final Guidance
How to determine whether your medical device maintenance, repair, or modification activity is FDA-defined servicing or remanufacturing — the 6 guiding principles from the May 2024 final guidance, the decision flowchart, automatically-classified activities, software change rules, documentation requirements, and regulatory exposure for OEMs, third-party servicers, and hospital HTM teams.
Field Service Traceability for Software-Enabled Medical Devices: Service Records, Software Change Logs, Audit Trails, and Regulatory Compliance Under FDA QMSR, ISO 13485, and 21 CFR Part 11
How to build a complete traceability system for field service on software-enabled medical devices — electronic service records, software version and configuration tracking, firmware update logs, audit trail requirements under 21 CFR Part 11, traceability for installed base management, complaint-to-service-record linkage, and FDA inspection readiness under QMSR and ISO 13485 Clause 7.5.9.
Preventive Maintenance and Calibration Interval Justification for Medical Devices: Risk-Based Methods, AEM Programs, and Regulatory Compliance Under ISO 13485, FDA QMSR, and Joint Commission Standards
How to establish and justify preventive maintenance and calibration intervals for medical devices — manufacturer recommendations vs. risk-based alternative approaches, statistical methods for interval optimization, reliability-centered maintenance for healthcare, Joint Commission EC.02.04.01 and AEM program requirements, AAMI EQ56 guidance, ISO 13485 Clause 7.5.1 and Clause 7.5.6, FDA 21 CFR Part 820 calibration requirements, and documentation for audit readiness.
Spare Parts Obsolescence and Approved Alternate Control for Medical Devices: Last-Time Buy, Alternate Part Qualification, Change Control, and Regulatory Compliance Under ISO 13485, FDA QMSR, and EU MDR
How to manage spare parts obsolescence for medical devices throughout the product lifecycle — proactive monitoring, last-time buy strategy, alternate part identification and qualification, verification and validation requirements, engineering change control, 510(k) assessment triggers, EU MDR obligations for discontinued devices, and building an obsolescence management program under ISO 13485 and FDA QMSR.
FDA One-Day AI Inspection Pilot: How Elsa Is Reshaping Medical Device Facility Oversight
Breaking down the FDA's May 2026 one-day inspection pilot that uses AI (Elsa) to target low-risk facilities. Covers how facilities are selected, what to expect during a screening inspection, how it differs from standard inspections, and what medical device manufacturers must do to stay ready.
QMSR Supplier Quality Agreement for Cloud, AI, Cybersecurity, and Testing Vendors: Clause-by-Clause Construction Guide
How to draft ISO 13485 / QMSR-compliant supplier quality agreements for critical outsourced vendors — cloud hosting providers, AI model/data vendors, penetration testing firms, ASCA/non-ASCA test labs, and sterilization vendors — with clause-by-clause guidance, vulnerability notification clauses, audit rights, CAPA cooperation, change notification, and evidence records.
SBOM-to-VEX Vulnerability Triage Workflow for Medical Devices: From CVE Intake to Field Action Decision
Operational playbook for medical device PSIRT teams — SBOM component matching, exploitability analysis, VEX justification authoring, PSIRT severity scoring, CAPA trigger thresholds, field safety corrective action decisions, and customer communication timing.
Global UDI Compliance 2026: Complete Deadlines Guide by Country (EU, US, Switzerland, Australia, China, Brazil, Singapore)
2026 is the most consequential year for medical device UDI compliance globally. Mandatory deadlines hit in the EU (May 28), Switzerland (July 1), Australia (July 1), and China. This guide covers every active UDI system, class-by-class deadlines, data requirements, and what happens if you miss them.
Medical Device CDMO Market 2026: $354B by 2033, Key Players, and Strategic Outsourcing Guide
The medical device CDMO market is projected to grow from $134.65 billion in 2025 to $354.60 billion by 2033 at 13.12% CAGR. This guide covers market size, growth drivers, key players (Jabil, Integer, Flex, Plexus), M&A trends, and how to choose the right contract manufacturing partner.
FDA Cybersecurity Premarket Submission Deficiencies: 12 Common Rejection Reasons and How to Fix Them (2026)
Practical guide to the top 12 FDA cybersecurity deficiencies causing premarket submission holds in 2026 — SBOM gaps, threat modeling failures, risk assessment mistakes, and fixes aligned with the February 2026 final guidance and Section 524B.
Design Review Evidence for Medical Devices: Agenda, Minutes, Independence, and FDA/ISO Expectations
Complete guide to medical device design review documentation — how to plan agendas, record minutes, ensure reviewer independence per FDA 21 CFR 820.30(e) and ISO 13485 Clause 7.3.5, and create audit-ready design review records under QMSR.
Batch Records for Medical Devices: Complete Guide to BMR, EBR, and DHR — Paper vs Electronic, 21 CFR 210/211 Compliance, and FDA QMSR Requirements
Master batch manufacturing records (BMR), electronic batch records (EBR), and device history records (DHR) for medical device manufacturing. Covers 21 CFR 210/211, 21 CFR Part 820/QMSR, ISO 13485, paper vs electronic systems, review workflows, deviation management, and FDA inspection readiness.
Cost of Quality (CoQ) in Medical Devices: Complete Framework — Prevention, Appraisal, Internal & External Failure Costs
How to calculate and reduce Cost of Quality in medical device manufacturing using the four-category model. Includes the 1-10-100 rule, McKinsey industry benchmarks (6.8–9.4% of sales), eQMS ROI data, and step-by-step implementation aligned with ISO 13485 and FDA QMSR.
CSV to CSA Transition: Complete Guide to FDA's 2025 Computer Software Assurance Final Guidance
How to transition from Computer System Validation (CSV) to Computer Software Assurance (CSA) under FDA's September 2025 final guidance — risk-based approach, testing strategies, documentation requirements, and step-by-step implementation roadmap.
Engineering Change Order (ECO) for Medical Devices: Complete Process Guide
How to manage Engineering Change Orders (ECOs) in medical device manufacturing — ECR to ECO to ECN workflow, ISO 13485 Clause 7.3.9 requirements, FDA QMSR design change control, risk assessment, regulatory notification triggers, and best practices for cross-functional approval.
Equipment Calibration Management for Medical Devices: ISO 13485 Clause 7.6 Complete Guide
How to build and manage an equipment calibration program for medical device manufacturing — ISO 13485 Clause 7.6 requirements, FDA QMSR compliance, NIST traceability, ISO 17025 accreditation, calibration schedules, out-of-tolerance procedures, and electronic calibration management.
FDA Inspection Readiness for Medical Devices: Complete Guide to QMSR Inspections in 2026
How to prepare for FDA medical device inspections under the new QMSR framework (CP 7382.850) — inspection types, the six QMS areas, common 483 observations, and a step-by-step readiness checklist.
FDA QMSR Inspection Preparation: Complete Guide to Compliance Program CP 7382.850
How to prepare for FDA medical device inspections under the new Compliance Program CP 7382.850 — six QMS areas, four OAFRs, risk-based inspection methodology, ISO 13485 alignment, and step-by-step readiness checklist.
GMP vs cGMP for Medical Devices: Complete Guide to Current Good Manufacturing Practice Under FDA QMSR (21 CFR 820)
Understand the difference between GMP and cGMP for medical device manufacturing. Covers FDA QMSR (effective Feb 2026), 21 CFR Part 820, ISO 13485:2016 harmonization, cGMP requirements for design controls, production, packaging, labeling, and FDA inspection readiness.